UPDATE: JP Morgan Raises PT to $50 on Cintas; Revenue Momentum Offsets EPS Miss
JP Morgan maintained Cintas (NASDAQ: CTAS) with an Overweight rating and raised the price target from $47.00 to $50.00.
JP Morgan analyst Andrew C. Steinerman commented, "Thursday evening, Cintas reported 3QF13 (Feb) revenues of $1,076mln, ~2% above our estimate, as organic same-day basis (SDB) revenue growth rose to 6.9% y/y (from 3.4% y/y in 2QF13 (Nov)). 3QF13 EPS was $0.60, slightly below our estimate of $0.63. … The new healthcare regulations represent a prospective CY2014 margin headwind, but in a healthy economy CTAS should have high enough top-line growth and operating levers to overcome this headwind, in our view."
Cintas closed at $45.93 on Tuesday.
Latest Ratings for CTAS
|Apr 2016||Nomura||Initiates Coverage on||Buy|
|Apr 2016||KeyBanc||Upgrades||Sector Weight||Overweight|
|Mar 2016||Sterne Agee CRT||Initiates Coverage on||Neutral|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.